Endologix gets FDA nod for AAA system

Kaitlyn Dmyterko | | Health Imaging | Screening
The FDA has approved Endologix’s AFX endovascular abdominal aortic aneurysm (AAA) system, an endovascular repair of abdominal aortic aneurysm device indicated to treat AAA.

The company said that AFX system’s ergonomic dial mechanism will provide control during stent graft positioning and deployment. All AFX stent grafts, which measure 13 to 34 millimeters in diameter, are delivered through a hydrophilically-coated 17 Fr introducer sheath.

Lastly, the AFX system includes the Strata expanded polytetrafluoroethylene graft that is constructed using Strata graft material.

Irvine, Calif.-based Endologix highlighted the AFX system last week at the annual Society for Vascular Surgery (SVS) meeting in Chicago June 16-18.

 

Kaitlyn Dmyterko

Related Content

Abbreviated MRI protocols present suitable alternatives for liver cancer screening
Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility

Around the web

Radiology Business
AI can help radiology standardize image exam data labeling

To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.